The Defense Health Agency is seeking a commercial partner to develop and manage Dimethyl Sulfoxide (DMSO) Cryopreserved Platelets (CPP), a biologic product designed to extend platelet shelf life to 2 years or more, compared to the current 5-7 days for liquid stored platelets. This product aims to enhance medical readiness and quality of life for active-duty personnel in operational environments. No specific budget amounts are mentioned in the description. The location for performance of services is not specified. No non-bid or submission timelines are provided.